Alicia E. Consolini

Prof. Dr. Alicia E. Consolini

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2006 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ACAlicia E. Consolini
Alicia E. Consolini
MRMaría Inés Ragone
María Inés Ragone
GMGraciela N. Migliori
Graciela N. Migliori
PCPaula Conforti
Paula Conforti
MVMaría G. Volonté
María G. Volonté

28 May 2017
Verified
Book Chapter
Closed access
PDF file
ACAlicia E. Consolini
Alicia E. Consolini
MRMaría I. Ragone
María I. Ragone
PBPatricia Bonazzola
Patricia Bonazzola
GCGermán A. Colareda
Germán A. Colareda

29 August 2018 in Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
CVCarlos A Valverde
Carlos A Valverde
GMGabriela Mazzocchi
Gabriela Mazzocchi
MCMariano N Di Carlo
Mariano N Di Carlo
APAlejandro Ciocci Pardo
Alejandro Ciocci Pardo
NSNehuen Salas
Nehuen Salas
AMAlicia Mattiazzi
Alicia Mattiazzi
Abnormal Ca2+ release from the sarcoplasmic reticulum (SR), associated with Ca2+-calmodulin kinase II (CaMKII)-dependent phosphorylation of RyR2 at Ser2814, has consistently been linked to arrhythmogenesis and ischaemia/reperfusion (I/R)-induced cell death. In contrast, the role played by SR Ca2+ uptake under these stress conditions remains controversial. We tested the hypothesis that an increase in SR Ca2+ uptake is able to attenuate reperfusion arrhythmias and cardiac injury elicited by increased RyR2-Ser2814 phosphorylation. We used WT mice, which have been previously shown to exhibit a transient increase in RyR2-Ser2814 phosphorylation at the onset of reperfusion; mice with constitutive pseudo-phosphorylation of RyR2 at Ser2814 (S2814D) to exacerbate CaMKII-dependent reperfusion arrhythmias and cardiac damage, and phospholamban (PLN)-deficient-S2814D knock-in (SDKO) mice resulting from crossbreeding S2814D with phospholamban knockout deficient (PLNKO) mice. At baseline, S2814D and SDKO mice had structurally normal hearts. Moreover none of the strains were arrhythmic before ischaemia. Upon cardiac I/R, WT, and S2814D hearts exhibited abundant arrhythmias that were prevented by PLN ablation. In contrast, PLN ablation increased infarct size compared with WT and S2814D hearts. Mechanistically, the enhanced SR Ca2+ sequestration evoked by PLN ablation in SDKO hearts prevented arrhythmogenic events upon reperfusion by fragmenting SR Ca2+ waves into non-propagated and non-arrhythmogenic events (mini-waves). Conversely, the increase in SR Ca2+ sequestration did not reduce but rather exacerbated I/R-induced SR Ca2+ leak, as well as mitochondrial alterations, which were greatly avoided by inhibition of RyR2. These results indicate that the increase in SR Ca2+ uptake is ineffective in preventing the enhanced SR Ca2+ leak of PLN ablated myocytes from either entering into nearby mitochondria and/or activating additional CaMKII pathways, contributing to cardiac damage. Our results demonstrate that increasing SR Ca2+ uptake by PLN ablation can prevent the arrhythmic events triggered by CaMKII-dependent phosphorylation of RyR2-induced SR Ca2+ leak. These findings underscore the benefits of increasing SERCA2a activity in the face of SR Ca2+ triggered arrhythmias. However, enhanced SERCA2a cannot prevent but rather exacerbates I/R cardiac injury.

1 January 2005 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ACAlicia E. Consolini
Alicia E. Consolini
GMGraciela N. Migliori
Graciela N. Migliori

1 May 2007 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
ACAlicia E. Consolini
Alicia E. Consolini
MRM.I. Ragone
M.I. Ragone
PCP. Conforti
P. Conforti
MVM.G. Volonté
M.G. Volonté
The role of the mitochondrial Na/Ca-exchanger (mNCX) in hearts exposed to ischemia–reperfusion (I/R) and pretreated with cardioplegia (CPG) was studied from a mechano-calorimetric approach. No-flow ischemia (ISCH) and reperfusion (REP) were developed in isolated rat hearts pretreated with 10 µmol/L clonazepam (CLZP), an inhibitor of the mNCX, and (or) a high K+– low Ca2+solution (CPG). Left ventricular end diastolic pressure (LVEDP), pressure development during beats (P), and the steady heat release (Ht) were continuously measured and muscle contents of ATP and PCr were analyzed at the end of REP. During REP, Htincreased more than P, reducing muscle economy (P/Ht) and the ATP content. CPG induced an increase in P recovery during REP (to 90% ± 10% of preISCH) with respect to nonpretreated hearts (control, C, to 64% ± 10%, p < 0.05). In contrast, CLZP reduced P recovery of CPG-hearts (50% ± 6.4%, p < 0.05) and increased LVEDP in C hearts. To evaluate effects on sarcoplasmic reticulum (SR) function, ischemic hearts were reperfused with 10 mmol/L caffeine –36 mmol/L Na (C – caff – low Na). It increased LVEDP, which afterwards slowly relaxed, whereas Htincreased (by about 6.5 mW/g). CLZP sped up the relaxation with higher ΔHt, C – caff – low Na produced higher contracture and lower Htin perfused than in ischemic hearts. Values of ΔHtwere compared with reported fluxes of Ca2+-transporters, suggesting that mitochondria may be in part responsible for the ΔHtduring C – caff – low Na REP. Results suggest that ISCH–REP reduced the SR store for the recovery of contractility, but induced Ca2+movement from the mitochondria to the SR stores. Also, mitochondria and SR are able to remove cytosolic Ca2+during overloads (as under caffeine), through the mNCX and the uniporter. CPG increases Ca2+cycling from mitochondria to the SR, which contributes to the higher recovery of P. In contrast, CLZP produces a deleterious effect on ISCH–REP associated with higher heat release and reduced resynthesis of high energy phosphates, which suggests the induction of mitochondrial Ca cycling and uncoupling.

1 October 2010 in Current Drug Safety
Verified
Journal Article
Closed access
PDF file
ACAlicia E. Consolini
Alicia E. Consolini
MRMaria Ines Ragone
Maria Ines Ragone
Medicinal plants are useful as a natural therapy to treat minor illnesses, as gastrointestinal disorders or as topic antiinflammatories. Also, they have been increasingly used as a coadjuvant in cronic diseases as hypertension, diabetes or hyperlipidemias. Nevertheless, many of the plants have active principles which are contraindicated or need precaution in certain illnesses as coagulation disorders or in certain states as pregnancy or breastfeeding. In this review we had compiled the side-effects, precautions and interactions with other medicines of many plants which are used in self-medication in our region. A previous population study gave us information on the consumption of medicinal plants in 73 pharmacies of the Buenos Aires province, in Argentina. During a period of one year, there were 37102 self-medicated plants, while only 1532 were prescribed by the physician. Among the most frequently selfmedicated plants are Malva sylvestris L., Matricaria chamomile L., and Quassia amara. Among the most frequently prescribed are also “malva” and “chamomile”, Tilia cordata Mill. and Valeriana officinalis. Based in the most consumed medicinal plants in our region, we reviewed the risks of such plants and the precautions that should be taken for a rational use. Also, we detected 15 adverse-reactions reported by the pharmacists through a pharmaceutical vigilance program, which are described and analyzed here. The results of the study and other reports suggest that adverse reactions of herbal medicines could be avoided if preventing self-medication, and taking into consideration possible contraindications and interactions.